ArticleBMC research notes2015

The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.

Carolien Boeckx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.